Trial · NCT07905846
A Hybrid Type 1 Randomized Controlled Trial of an Online and Text-Messaging Intervention to Prevent Alcohol and Cannabis Initiation, Escalation, and Consequences Among First-Year College Students
NCT07905846, Not applicable, Not yet recruiting, The University of Texas at Arlington
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Hybrid Type 1 Randomized Controlled Trial of an Online and Text-Messaging Intervention to Prevent Alcohol and Cannabis Initiation, Escalation, and Consequences Among First-Year College Students. Trials, record NCT07905846. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07905846
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Hybrid Type 1 Randomized Controlled Trial of an Online and Text-Messaging Intervention to Prevent Alcohol and Cannabis Initiation, Escalation, and Consequences Among First-Year College Students
- NCT number
- NCT07905846
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 800 participants, estimated
- Lead sponsor
- The University of Texas at Arlington
- Conditions
- Alcohol, Cannabis
- Interventions
- Online and Text Message Intervention
- First posted
- 2026-10-30
- Last updated
- 2026-10-30
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Alcohol Initiation | From enrollment to 8 month follow-up | Alcohol initiation for those who abstain at baseline will be calculated as time-to-event from baseline date to the approximate date they first used alcohol. |
| Primary | Cannabis Initiation | From enrollment to 8 month follow-up | Cannabis initiation for those who abstain at baseline will be calculated as time-to-event from baseline date to the approximate date they first used cannabis |
| Primary | Alcohol Consumption | 4 and 8 month follow-up | Alcohol consumption will be assessed using the Daily Drinking Questionnaire, a validated self-report measure assessing the number of standard alcoholic drinks typically consumed on each day of the week, allowing calculation of typical weekly alcohol consumption and drinking frequency. |
| Primary | Cannabis Consumption | 4 and 8 month follow-up | Cannabis consumption will be assessed using a measure parallel to the Daily Drinking Questionnaire, and will assess the number of hours high on each day of the week, allowing calculation of typical cannabis use and frequency. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| R01AA033553 | A Hybrid Type 1 Randomized Controlled Trial of an Online and Text-Messaging Intervention to Prevent Alcohol and Cannabis Initiation, Escalation, and Consequences Among First-Year College Students | Litt, Dana M. | UNIVERSITY OF TEXAS ARLINGTON | NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM | 2026 |
Source NIH RePORTER
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07905846
GET https://conductscience.org/api/trials/v1/NCT07905846/registered